Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BEAM | Common Stock | Options Exercise | $74.2K | +5.43K | +17.35% | $13.68 | 36.7K | Jan 23, 2023 | Direct | F1 |
transaction | BEAM | Common Stock | Sale | -$244K | -5.43K | -14.78% | $45.02 | 31.3K | Jan 23, 2023 | Direct | F2, F3 |
transaction | BEAM | Common Stock | Options Exercise | $203K | +14.8K | +47.35% | $13.68 | 46.1K | Jan 24, 2023 | Direct | F1 |
transaction | BEAM | Common Stock | Sale | -$667K | -14.8K | -32.13% | $45.01 | 31.3K | Jan 24, 2023 | Direct | F2, F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BEAM | Stock Option (Right to Buy) | Options Exercise | $0 | -5.43K | -2.23% | $0.00 | 238K | Jan 23, 2023 | Common Stock | 5.43K | $13.68 | Direct | F1, F5 |
transaction | BEAM | Stock Option (Right to Buy) | Options Exercise | $0 | -14.8K | -6.23% | $0.00 | 223K | Jan 24, 2023 | Common Stock | 14.8K | $13.68 | Direct | F1, F5 |
Id | Content |
---|---|
F1 | The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
F3 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.18, inclusive. The Reporting Person undertakes to provide Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
F4 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.10, inclusive. The Reporting Person undertakes to provide BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
F5 | The option vested as to 25% on the first anniversary of the of the vesting commencement date, August 20, 2019, and continues to vest at a rate of 2.78% each month thereafter until the option is fully vested. |